TTRX
NASDAQ · Pharmaceuticals
Turn Therapeutics Inc
$15.29
-0.05 (-0.33%)
Open$15.31
Previous Close$15.34
Day High$15.44
Day Low$14.53
52W High$26.50
52W Low$2.57
Volume—
Avg Volume158.0K
Market Cap413.90M
P/E Ratio—
EPS$-0.29
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 28.41M | 28.26M | 24.54M |
| Net Income | 5.07M | 4.33M | 4.07M |
| Profit Margin | 17.8% | 15.3% | 16.6% |
| EBITDA | 7.12M | 6.76M | 5.89M |
| Free Cash Flow | 5.68M | 5.26M | 4.99M |
| Rev Growth | +18.7% | -2.9% | -7.4% |
| Debt/Equity | 0.72 | 0.77 | 0.81 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |